Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus, Chronic Kidney Diseases

In brief

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Key facts

Study ID
NCT05099770
Run by
Prokidney
People needed
685
Starts
2022-01-05
Expected to finish
2029-12-01
Last updated by the study team
2026-03-23

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.